System for screening particles

Abstract

Screening of a library of particles in vivo and/or in vitro using Polyplex Iterative Combinatorial Optimization (PICO) allows for the design of particles for targeting a specific organ, tissue (e.g., cancer), or cell. Particles may, for example, include different targeting agents (e.g., aptamers or plurality of aptamers) on their surfaces, and the aptamer or aptamers may be evolved to provide better targeting of the particles. Libraries of particles are enriched in characteristics of particles that have been found to migrate to a tissue of interest, be taken up by cells, etc. The process may be repeated to engineer particles of a desired specificity or biological function.

We claim: 
     
         1 - 135 . (canceled) 
     
     
         136 . A high throughput, iterative, combinatorial screening method of identifying particle properties providing enhanced delivery of particles to targeted cells, the method comprising the steps of
 providing a plurality of synthetic polymeric particle populations,   wherein the particles of each population have substantially the same composition, size, density, surface chemistry, ligand or density of ligand bound thereto, wherein the particles of a given particle population differ from the particles of another given particle population by at least one particle characteristic, and   wherein each particle of a given population has at least one detectable label which is different from the detectable label of the particles of another given particle population and is different from the targeting agent;   administering the plurality of particle populations to an animal under conditions in which the particles are delivered to targeted cells; and   enriching the delivered particles by repeating the process with different populations of particles, each population having at least one different particle characteristic, thereby determining the particle characteristics which enhance delivery of the particles to the targeted cells.   
     
     
         137 . The method of claim  1 , wherein the particles have on the surface thereof a ligand selected from the group consisting of an oligonucleotide, a polysaccharide, an antibody, an antibody fragment, a nucleic acid ligand, a lipoprotein, folate, transferrin, an asialycoprotein, an enzymatic receptor ligand, sialic acid, a glycoprotein, a lipid, a small molecule, metal, metal complex, a bioactive agent, and an immunoreactive fragment. 
     
     
         138 . The method of claim  1 , wherein the detectable label is selected from the group consisting of a luminescent agent, a chemiluminescent agent, a phosphorescent agent, a fluorescent agent, a radionuclide, a small molecule, a mass spectroscopy tag, a polynucleotide, a polypeptide, a semiconductor particle, a magnetic material, an ultrasound contrast agent, an MM contrast agent, and an x-ray contrast agent. 
     
     
         139 . The method of claim  3 , wherein the label is disposed on the surface of the particle, in the interior of the particle, or both. 
     
     
         140 . The method of claim  1  further comprising the step of recovering particles that have migrated to non-targeted cells. 
     
     
         141 . The method of claim  1 , wherein the particles are selected from the group consisting of microparticles, nanoparticles, and picoparticles. 
     
     
         142 . The method of claim  1 , wherein the polymer is selected from the group consisting of polyesters, polyamides, polycarbonates, polycarbamates, polyacrylates, polystyrene, polyureas, polyethers, polyamines, polyanhydrides, poly(hydroxyacids), poly(lactic acid), poly(glycolic acid), poly(orthoesters), polyphosphazene, ethylene-vinyl acetate copolymer, polyurethanes, polyacrylates, polymethacrylates, polyacrylonitriles, poly(amidoamine) dendrimers, poly(L-lactide-co-L-lysine), poly(serine ester), poly(4-hydroxy-L-proline ester), maleimide-poly(ethyleneglycol)-block-poly(D,L-lactic acid); COOH-poly(ethyleneglycol)-block-poly(D,L-lactic acid); methoxypoly(ethyleneglycol)-block-poly(D,L-lactic acid); proteins; polysaccharides, PEGylated poly(hydroxy acids), PEGylated poly(orthoesters), poly(caprolactone), PEGylated poly(caprolactone), polylysine, PEGylated polylysine, poly(ethylene imine), PEGylated poly(ethylene imine), and combinations thereof. 
     
     
         143 . The method of  claim 142 , wherein the particles are poly(lactic-co-glycolic acid) (PLGA) particles. 
     
     
         144 . The method of claim  1 , wherein the particles comprise a poly(hydroxy acid) polymer or copolymer or pegylated poly(hydroxy acid) polymer or copolymer. 
     
     
         144 . The method of claim  1 , wherein the particles comprise at least one targeting agent. 
     
     
         146 . The method of claim  1 , wherein the particles comprise a plurality of targeting agents. 
     
     
         147 . The method of claim  1  wherein the particles of each of the given particle population have different ligand conjugated to their surface. 
     
     
         148 . The method of claim  1  wherein the particles comprise a therapeutic or prophylactic agent for delivery to the targeted cells.